OBALON THERAPEUTICS INC·4

Aug 27, 9:32 PM ET

Rasdal Andrew P 4

4 · OBALON THERAPEUTICS INC · Filed Aug 27, 2018

Insider Transaction Report

Form 4
Period: 2018-08-23
Rasdal Andrew P
DirectorPresident & CEO
Transactions
  • Award

    Common Stock

    2018-08-23$1.82/sh+109,890$200,000566,948 total
Footnotes (1)
  • [F1]The reporting person purchased these shares directly from the issuer in a private placement.

Documents

1 file
  • 4
    marketforms-42783.xmlPrimary

    PRIMARY DOCUMENT